[Ala107]MBP (104-118) (TFA)

[Ala107]MBP (104-118) TFA is an noncompetitive peptide inhibitors of protein kinase C (PKC), with IC50s ranging from 46-145 μM[1].

Product Specifications

UNSPSC

12352209

Target

PKC

Type

Peptides

Related Pathways

Epigenetics; TGF-beta/Smad

Applications

Cancer-Kinase/protease

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/ala107-mbp-104-118-tfa.html

Solubility

H2O

Smiles

OC(C(F)(F)F)=O.O=C(CN)N[C@H](C(NCC(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(O)=O)C)=O)=O)CC1=CNC2=CC=CC=C12)=O)CO)=O)CC3=CC=CC=C3)=O)CCCNC(N)=N)=O)CO)=O)CC(C)C)=O)CO)=O)CC(C)C)=O)=O)C)=O)=O)CCCCN

Molecular Formula

C69H105F3N20O21

Molecular Weight

1607.69

References & Citations

[1]Su HD, et, al. Synthetic myelin basic protein peptide analogs are specific inhibitors of phospholipid/calcium-dependent protein kinase (protein kinase C) . Biochem Biophys Res Commun. 1986 Jan 14; 134 (1) : 78-84.